March 24 (Reuters) - BIOSYNEX SA ALBIO.PA :
* FY TURNOVER AT €153.9M VERSUS €35.2M
* FY EBITDA MULTIPLIED BY 22.6 TO €52.0M
* PROPOSITION OF DIVIDEND OF 0,20 EUR PER SHARE
* GROUP IS CONFIDENT OF MAINTAINING HIGH SALES OF COVID-19
RAPID
TESTS AND HAS SEEN STRONG REVENUE GROWTH SINCE THE BEGINNING OF
2021
* OVER THE NEXT FEW YEARS, BIOSYNEX EXPECTS EXPORTS TO
BECOME THE
GROUP'S MAIN GROWTH AREA
Source text: https://bit.ly/3ckCAlw
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))